AOCNP EXAM STUDY GUIDE – QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED
ANSWERS | PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains
1. Pathophysiology and Oncology Basics
2. Pharmacology and Chemotherapy/Biotherapy
3. Symptom Management and Supportive Care
4. Diagnostic and Staging Procedures
5. Radiation Oncology Principles
6. Surgical Oncology and Interventional Procedures
7. Psychosocial and Ethical Issues
8. Survivorship and Palliative Care
9. Clinical Trials and Research Methodology
10. Professional Practice and Legal Standards
Introduction
This comprehensive examination is designed to rigorously assess the knowledge, clinical reasoning,
and decision-making skills essential for the Advanced Oncology Certified Nurse Practitioner. The
assessment encompasses a broad spectrum of foundational theory, applied clinical knowledge, and
regulatory standards integral to oncology practice. Through a series of multiple-choice and scenario-
based questions, candidates will demonstrate their ability to synthesize complex information, prioritize
patient care, and apply evidence-based guidelines in diverse clinical situations. This exam emphasizes
real-world application, evaluating the practitioner's capacity to manage treatment-related toxicities,
navigate ethical dilemmas, and coordinate comprehensive care across the oncology continuum.
Success on this examination reflects a mastery of the core competencies required for advanced
oncology nursing practice.
Section One: Questions 1 – 100
1. A patient with chronic myeloid leukemia (CML) is started on imatinib. Which of the following is
the primary mechanism of action of this medication?
A. Inhibition of tyrosine kinase activity
B. Induction of apoptosis in resting cells
C. Blockade of angiogenesis
D. Inhibition of topoisomerase II
🟢A
🔴 Explanation: Imatinib is a targeted therapy that specifically inhibits the BCR-ABL tyrosine kinase,
which is the hallmark of CML. This inhibition prevents the proliferation of leukemic cells without
affecting normal cells in the same way.
2. A 68-year-old patient with ovarian cancer is receiving cisplatin. What is the most critical pre-
administration assessment the oncology NP must perform?
,A. Blood pressure measurement
B. Serum electrolyte and renal function tests
C. Peripheral neurologic examination
D. Audiometry
🟢B
🔴 Explanation: Cisplatin is a highly nephrotoxic chemotherapy agent. Assessing renal function via
serum creatinine and electrolytes is mandatory to determine if the drug can be safely administered
and to guide hydration protocols.
3. A patient undergoing radiation therapy for prostate cancer reports fatigue and a dry cough.
What is the most appropriate initial intervention?
A. Order a chest x-ray to rule out radiation pneumonitis
B. Prescribe a corticosteroid inhaler
C. Increase the dose of the radiation therapy
D. Discontinue the treatment immediately
🟢A
🔴 Explanation: Radiation pneumonitis is a known complication of thoracic or, in this case, lower-
field radiation and presents with a dry cough. The first step is a chest x-ray to confirm the diagnosis
before initiating treatment with corticosteroids.
4. Which of the following is a characteristic feature of malignant pleural effusion?
A. Clear, straw-colored fluid
B. Low protein content
C. Exudative nature and presence of malignant cells
D. pH greater than 7.4
🟢C
🔴 Explanation: A malignant pleural effusion is classified as an exudate, characterized by high
protein content and the presence of malignant cells on cytologic examination. Other signs may
include high LDH and low glucose.
5. The NP is counseling a patient with a BRCA1 mutation. The patient is interested in prophylactic
surgery. Which surgery is most strongly recommended for risk reduction in this population?
A. Prophylactic mastectomy and oophorectomy
B. Prophylactic hysterectomy
C. Prophylactic colectomy
D. Prophylactic thyroidectomy
🟢A
🔴 Explanation: Women with a BRCA1 mutation have a significantly increased risk for breast and
ovarian cancers. Prophylactic mastectomy and oophorectomy are the most effective risk-reducing
surgeries.
, 6. A patient receiving FOLFOX (5-FU, leucovorin, oxaliplatin) for colon cancer develops cold-
induced dysesthesia of the hands and throat. This is a classic sign of what condition?
A. Cumulative neuropathy from 5-FU
B. Hypersensitivity reaction to leucovorin
C. Oxaliplatin neurotoxicity
D. Myelosuppression
🟢C
🔴 Explanation: Oxaliplatin is notorious for causing acute, cold-induced peripheral neuropathy
characterized by paresthesias and dysesthesias triggered by cold exposure. This is a dose-limiting
toxicity.
7. According to the National Comprehensive Cancer Network (NCCN) guidelines, what is the
preferred prophylactic antiemetic regimen for a patient receiving a highly emetogenic
chemotherapy regimen (e.g., AC for breast cancer)?
A. Aprepitant + a 5-HT3 antagonist + dexamethasone
B. Prochlorperazine alone
C. Olanzapine + metoclopramide
D. Lorazepam + diphenhydramine
🟢A
🔴 Explanation: For highly emetogenic chemotherapy, the standard triple therapy includes a
neurokinin-1 receptor antagonist (aprepitant), a serotonin receptor antagonist (ondansetron), and a
corticosteroid (dexamethasone).
8. A patient with multiple myeloma develops hypercalcemia. What is the first-line pharmacologic
treatment for acute management?
A. Denosumab
B. Calcitonin
C. Pamidronate
D. Sevelamer
🟢C
🔴 Explanation: Bisphosphonates, such as pamidronate or zoledronic acid, are the mainstay of
treatment for tumor-induced hypercalcemia. They work by inhibiting osteoclast-mediated bone
resorption and are preferred for acute management.
9. A patient presents with erythema and desquamation in the radiation field. This is classified as
which grade of radiation dermatitis?
A. Grade 1
B. Grade 2
C. Grade 3
D. Grade 4
🟢B
ANSWERS | PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains
1. Pathophysiology and Oncology Basics
2. Pharmacology and Chemotherapy/Biotherapy
3. Symptom Management and Supportive Care
4. Diagnostic and Staging Procedures
5. Radiation Oncology Principles
6. Surgical Oncology and Interventional Procedures
7. Psychosocial and Ethical Issues
8. Survivorship and Palliative Care
9. Clinical Trials and Research Methodology
10. Professional Practice and Legal Standards
Introduction
This comprehensive examination is designed to rigorously assess the knowledge, clinical reasoning,
and decision-making skills essential for the Advanced Oncology Certified Nurse Practitioner. The
assessment encompasses a broad spectrum of foundational theory, applied clinical knowledge, and
regulatory standards integral to oncology practice. Through a series of multiple-choice and scenario-
based questions, candidates will demonstrate their ability to synthesize complex information, prioritize
patient care, and apply evidence-based guidelines in diverse clinical situations. This exam emphasizes
real-world application, evaluating the practitioner's capacity to manage treatment-related toxicities,
navigate ethical dilemmas, and coordinate comprehensive care across the oncology continuum.
Success on this examination reflects a mastery of the core competencies required for advanced
oncology nursing practice.
Section One: Questions 1 – 100
1. A patient with chronic myeloid leukemia (CML) is started on imatinib. Which of the following is
the primary mechanism of action of this medication?
A. Inhibition of tyrosine kinase activity
B. Induction of apoptosis in resting cells
C. Blockade of angiogenesis
D. Inhibition of topoisomerase II
🟢A
🔴 Explanation: Imatinib is a targeted therapy that specifically inhibits the BCR-ABL tyrosine kinase,
which is the hallmark of CML. This inhibition prevents the proliferation of leukemic cells without
affecting normal cells in the same way.
2. A 68-year-old patient with ovarian cancer is receiving cisplatin. What is the most critical pre-
administration assessment the oncology NP must perform?
,A. Blood pressure measurement
B. Serum electrolyte and renal function tests
C. Peripheral neurologic examination
D. Audiometry
🟢B
🔴 Explanation: Cisplatin is a highly nephrotoxic chemotherapy agent. Assessing renal function via
serum creatinine and electrolytes is mandatory to determine if the drug can be safely administered
and to guide hydration protocols.
3. A patient undergoing radiation therapy for prostate cancer reports fatigue and a dry cough.
What is the most appropriate initial intervention?
A. Order a chest x-ray to rule out radiation pneumonitis
B. Prescribe a corticosteroid inhaler
C. Increase the dose of the radiation therapy
D. Discontinue the treatment immediately
🟢A
🔴 Explanation: Radiation pneumonitis is a known complication of thoracic or, in this case, lower-
field radiation and presents with a dry cough. The first step is a chest x-ray to confirm the diagnosis
before initiating treatment with corticosteroids.
4. Which of the following is a characteristic feature of malignant pleural effusion?
A. Clear, straw-colored fluid
B. Low protein content
C. Exudative nature and presence of malignant cells
D. pH greater than 7.4
🟢C
🔴 Explanation: A malignant pleural effusion is classified as an exudate, characterized by high
protein content and the presence of malignant cells on cytologic examination. Other signs may
include high LDH and low glucose.
5. The NP is counseling a patient with a BRCA1 mutation. The patient is interested in prophylactic
surgery. Which surgery is most strongly recommended for risk reduction in this population?
A. Prophylactic mastectomy and oophorectomy
B. Prophylactic hysterectomy
C. Prophylactic colectomy
D. Prophylactic thyroidectomy
🟢A
🔴 Explanation: Women with a BRCA1 mutation have a significantly increased risk for breast and
ovarian cancers. Prophylactic mastectomy and oophorectomy are the most effective risk-reducing
surgeries.
, 6. A patient receiving FOLFOX (5-FU, leucovorin, oxaliplatin) for colon cancer develops cold-
induced dysesthesia of the hands and throat. This is a classic sign of what condition?
A. Cumulative neuropathy from 5-FU
B. Hypersensitivity reaction to leucovorin
C. Oxaliplatin neurotoxicity
D. Myelosuppression
🟢C
🔴 Explanation: Oxaliplatin is notorious for causing acute, cold-induced peripheral neuropathy
characterized by paresthesias and dysesthesias triggered by cold exposure. This is a dose-limiting
toxicity.
7. According to the National Comprehensive Cancer Network (NCCN) guidelines, what is the
preferred prophylactic antiemetic regimen for a patient receiving a highly emetogenic
chemotherapy regimen (e.g., AC for breast cancer)?
A. Aprepitant + a 5-HT3 antagonist + dexamethasone
B. Prochlorperazine alone
C. Olanzapine + metoclopramide
D. Lorazepam + diphenhydramine
🟢A
🔴 Explanation: For highly emetogenic chemotherapy, the standard triple therapy includes a
neurokinin-1 receptor antagonist (aprepitant), a serotonin receptor antagonist (ondansetron), and a
corticosteroid (dexamethasone).
8. A patient with multiple myeloma develops hypercalcemia. What is the first-line pharmacologic
treatment for acute management?
A. Denosumab
B. Calcitonin
C. Pamidronate
D. Sevelamer
🟢C
🔴 Explanation: Bisphosphonates, such as pamidronate or zoledronic acid, are the mainstay of
treatment for tumor-induced hypercalcemia. They work by inhibiting osteoclast-mediated bone
resorption and are preferred for acute management.
9. A patient presents with erythema and desquamation in the radiation field. This is classified as
which grade of radiation dermatitis?
A. Grade 1
B. Grade 2
C. Grade 3
D. Grade 4
🟢B
